Patient/caregiver was educated on measures for managing side effects of Semaglutide use as follows: Frequent presentation with hypoglycemic symptoms and other serious side-effects discussed above should be notified to the physician for appropriate intervention. Measures can be implemented to manage the less severe side-effects involving the gastrointestinal system. Eating slowly and in smaller portions can help reduce the severity of abdominal discomfort with Semaglutide use. This can also help with better control of blood sugar [...]

Patient/caregiver was educated on the side effects of using Semaglutide as follows: Most common side-effects with Semaglutide use relate to the actions of the medication itself - lowered blood sugars and delayed gastric emptying. Lowered blood sugars with Semaglutide use can result in hypoglycemia and consequently, individuals can present with dizziness, headache, confusion, fast pounding heart rate, blurred vision, fatigue, mood changes, irritability, and hunger. Semaglutide use can cause a wide range of side-effects involving [...]

Patient/caregiver was instructed regarding priming the Semaglutide pen as follows: If you are using a new Semaglutide pen, always remember to make sure the label on the pen matches the medication you are prescribed. Always remember to prime the new pen. You do this only once for every pen that you use for the first time. Turn the dose adjustor until the flow check symbol aligns with the pointer. Hold the pen with needle pointing [...]

Patient/caregiver was educated on administering Semaglutide as follows: Semaglutide comes as a prefilled pen and is used as a once-a-week administration subcutaneously for control of blood sugar in patients with Type 2 diabetes. Semaglutide is injected subcutaneously, under the skin of the abdomen, thigh, or upper arm. Before every use, make sure the medication in the pen is clear and not cloudy. Refrain from using any pen with cloudy appearance of the medication and let [...]

Patient/caregiver was instructed regarding mechanism of action of Semaglutide as follows: Semaglutide binds to Glucagon-like peptide -1 hormone receptors on pancreatic beta cells and acts as an agonist at these receptors. This helps the beta cells of pancreas to release more insulin in response to elevated blood sugar levels. This released insulin helps move the sugar from the blood into the cells, thus reducing the blood sugar levels. Glucagon is a hormone produced by the [...]